semaglutide approved for mash 🎉Exciting news that is now FDA (aka fatty liver disease) “At week 72, the primary efficacy endpoint was based on histology (liver biopsy results). Interim results showed 63% FDA Grants Accelerated Approval of

The difference is in its indications

The longer that food in your stomach, the greater the chance it will create gas that needs to go out

More importantly, cardiovascular and renal outcome studies have demonstrated that GLP-1RAs and related multi-receptor agonists not only lower body weight and blood glucose but also significantly reduce the risk of major adverse cardiovascular events (MACE) and the worsening of renal function

Discontinue Compounded Liraglutide if suspected and promptly seek medical advice

BPC-157 is one of the most exciting regenerative tools we have in holistic veterinary medicine

The most commonly reported effects include nausea, changes in bowel habits, mild gastrointestinal discomfort, and temporary appetite fluctuations